4heal Technology secures exclusive multi-million dollar pre-seed investment from Aimei Health Technology II, focusing on Web3 health AI new infrastructure

ChainCatcher News, an innovative force in the Web3 health AI field, 4heal Technology announced today that it has successfully completed a Pre-Seed round of funding worth several million dollars at a valuation of $35 million. This round of financing was exclusively strategic investment from Nasdaq-listed company Aimei Health Technology II (US:AHJK).

The announcement stated that the funds will be primarily invested in Web3 AI health Agents, wearable device DePIN Network, and the development of a decentralized de-identified health data commercialization platform, aiming to promote privacy protection, value flow, and commercial applications of health data from the underlying architecture layer. 4heal is redefining the standards of intelligent health management. The company is committed to using decentralized technology to equip each user with an AI health smart steward that can “deeply understand body language” and “respond to emergency needs in real-time,” while ensuring the privacy sovereignty of personal and family data, and building a sustainable Web3 health AI business ecosystem.

It is reported that this transaction not only represents an important extension of Aimei Health Technology II (US:AHJK)’s global layout of high-quality health technology assets but also marks the official opening of 4heal Technology’s international capital channel, achieving an effective link between technological innovation and the capital market.